Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • India
  • COVID UPDATE: Indian genes against the coronavirus

Heparin sulfate: the key to coronavirus infection

Another cause of Hepatocellular Carcinoma (HCC) apart from alcoholism

COVID UPDATE: Indian genes against the coronavirus
  • India

COVID UPDATE: Indian genes against the coronavirus

bioxone September 18, 2020September 18, 2020

-Binayak Das, Team bioXone

A team of scientists claims that Indians should be grateful to their genetics, which according to their study is a critical factor in having a comparatively lesser number of deaths from COVID-19 in their populations. They studied the complete DNA data of the ACE2 gene in the X chromosomes from different continental populations. In their study published in PLOS ONE, the mention probable reasons for lower mortality rates were observed amongst Indian populations against US or European populations.

In their study, they conducted a haplotype-based analysis of the ACE2 gene, to study all of its possible genetic mutations in great depth. They found that certain mutations are possibly helping the South and East Asian populations by improving their resistance against the novel coronavirus, leading to a lower number of fatalities. The similarity in the DNA fragments between the South Asian and East Asian populations was found to be significantly similar, which might explain the lower mortality rate observed in both of these populations. They reported two major mutations of the ACE2 gene which were found to be responsible for improving the entry point of the virus, to be of key importance in establishing the resistance.

The team composed of Rudra Pandey and Prajwal Singh from BHU, Avinash Rasalkar, Pankaj Srivastava from Sagar Central University, Rakesh Tamang from Calcutta University and Pramod Kumar from National Centre for Disease Control (NCDC), Prof. George van Driem of University of Bern, Switzerland, and others believe that their study will help researchers to better understand the patterns of transmission of the deadly virus.

Source:  Anshika Srivastava, Rudra Kumar Pandey, Pramod Kumar, Avinash Arvind Rasalkar, Rakesh Tamang, Pankaj Shrivastava, Gyaneshwer Chaubey, Most frequent South Asian haplotypes of ACE2 share identity by descent with East Eurasian populations, Evolutionary Genetics 10.21203/rs.3.rs-27310/v1 Link- https://www.researchsquare.com/article/rs-27310/v1

For more news please visit https://bioxone.in//

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged ACE2 ACE2 receptor BHU calcutta university Covid covid cases in india COVID INDIA covid status india lower mortality rate mutations of the ACE2

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • World

Another cause of Hepatocellular Carcinoma (HCC) apart from alcoholism

bioxone September 18, 2020

-Sristi Raj Rai, Amity University Kolkata Alcohol consumption is not always the cause of hepatocellular carcinoma (HCC). People who drink little or no amount of alcohol can also develop a symptomless condition named non-alcoholic fatty liver disease (NAFLD), resulting from excessive storage of fats in liver cells that are now common among the masses. An […]

Hepatocellular Carcinoma

Related Post

  • BiotechToday
  • India
  • World

Can high systemic inflammation biomarkers during puberty result in breast cancer?

bioxone October 4, 2020October 3, 2020

Devyani Goswami, Amity University Kolkata Breast cancer has become one of the common diseases affecting both men and women worldwide, though most common in women as of yet. There are multifactorial reasons for the formation of breast cancer, depending on the type of breast cancer. A common trait observed in all cancer patients is an […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • India
  • Latest

COVID UPDATE: Russian Covid-19 vaccine Phase 3 trials to start in India this month, Preliminary Results by November

bioxone September 7, 2020September 7, 2020

–Sayak Biswas, Amity University Kolkata When the world is trying to fight through the Covid-19 pandemic, Scientists and Researchers are silently working to develop vaccines which can lead to some relief. There are currently a huge number of vaccines under developed for Covid-19. One among them is the Russian vaccine Sputnik V. The Russian vaccine […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

COVAXIN : India’s preparation for massive vaccination drive.

bioxone January 10, 2021January 9, 2021

-Chitra Roy, University of Calcutta Covaxin, India’s indigenous COVID-19 vaccine, has been a subject of criticism due to its approval for restricted emergency use despite hot having published any phase 3 efficacy data. However, until recently, Bharat Biotech, the manufacturer of Covaxin claimed that its vaccine potentially generated safety data with the robust immune response […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy